SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
77.17 +1.80  +2.39% NYSE Arca Aug 22, 20:00 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -6.69% -4.98% 91
3M 9.18% 3.16% 3
6M 9.41% 5.44% 9
1Y 22.18% 8.28% 4
3Y 14.73% 7.44% 4
5Y 21.79% 16.68% 1
10Y 15.85% 11.41% 2
As of Aug. 22, 2017. Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.15% 0.15% 0.00
Stock 99.85% 99.85% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Aug. 21, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Aug. 21, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Aug. 21, 2017

XBI Stock Market Capitalization

Giant 8.39%
Large 11.03%
Medium 22.49%
Small 35.94%
Micro 22.15%
As of Aug. 21, 2017

XBI Stock Style Exposure

Large Cap Value 2.16%
Large Cap Blend 6.79%
Large Cap Growth 11.71%
Mid Cap Value 0.00
Mid Cap Blend 2.02%
Mid Cap Growth 21.91%
Small Cap Value 1.84%
Small Cap Blend 9.62%
Small Cap Growth 43.95%
As of Aug. 21, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
KITE Kite Pharma Inc 3.01% 135.95 +1.52%
EXEL Exelixis Inc 2.70% 27.00 +2.39%
ALXN Alexion Pharmaceuticals Inc 2.50% 138.20 +3.57%
VRTX Vertex Pharmaceuticals Inc 2.40% 155.48 +4.34%
NBIX Neurocrine Biosciences Inc 2.36% 52.66 +1.02%
CLVS Clovis Oncology Inc 2.33% 72.10 +1.26%
ALNY Alnylam Pharmaceuticals Inc 2.30% 85.80 +1.32%
EXAS Exact Sciences Corp 2.28% 40.52 +4.73%
SRPT Sarepta Therapeutics Inc 2.24% 36.95 +3.41%
ACAD ACADIA Pharmaceuticals Inc 2.23% 31.44 +1.62%
As of Aug. 21, 2017
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 2.50 yrs
Michael Feehily 5.50 yrs
Raymond Donofrio 0.32 yrs

XBI Net Fund Flows

1M 69.95M
3M 167.67M
6M 386.30M
YTD 396.18M
1Y 839.14M
3Y 1.682B
5Y 1.670B
10Y 2.185B
As of July 31, 2017

XBI Risk Info

Beta (5Y) 1.603
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.7632
Historical Sortino (All) 0.9907
30-Day Rolling Volatility 20.90%
Daily Value at Risk (VaR) 1% (All) 4.88%
Monthly Value at Risk (VaR) 1% (All) 21.35%

XBI Fundamentals

Dividend Yield TTM (8-22-17) 0.23%
SEC Yield (8-21-17) 0.22%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.110
Weighted Average Price to Book Ratio 5.983
Weighted Median ROE -15.90%
Weighted Median ROA -21.38%
Forecasted Dividend Yield 0.22%
Forecasted PE Ratio 26.03
Forecasted Price to Sales Ratio 5.609
Forecasted Price to Book Ratio 4.660
Number of Holdings 98
As of Aug. 21, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 10.58%
Forecasted Book Value Growth 11.81%
Forecasted Cash Flow Growth 24.02%
Forecasted Earnings Growth 19.71%
Forecasted Revenue Growth 24.97%
As of Aug. 21, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.